Compass Therapeutics CMPX
NASDAQ CMPX
$0.82 -0.01 (-1.51%)
As of: Oct 21, 2026 · 11:41 AM EDT

Compass Therapeutics (CMPX) EBT Margin (2024)

Updated

Compass Therapeutics (CMPX) reported EBT Margin of -6661.76% for FY2024.

Analysis

Compass Therapeutics (CMPX) EBT Margin (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 26.66%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 25.18%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -4.11%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 18.19%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 27.53%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -131.41%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -4.34%
10 Compass Therapeutics 153.18 Mn -652.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1,538.35%
API Access

Compass Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=CMPX&period=max&api_key=YOUR_API_KEY